Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy C Moore

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Current Allergy and Asthma Reports|February 25, 2017
Phenotype-Driven Therapeutics in Severe AsthmaMaria Theresa D Opina, Wendy C Moore
Clinics in Chest Medicine|January 30, 2019
Three Major Efforts to Phenotype Asthma: Severe Asthma Research Program, Asthma Disease Endotyping for Personalized Therapeutics, and Unbiased Biomarkers for the Prediction of Respiratory Disease OutcomePhilip E Silkoff, Wendy C Moore, Peter J Sterk
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Difficult-to-Control Asthma Management in AdultsAndrew Menzies-Gow, Wendy C Moore, Michael E Wechsler
AORN Journal|March 30, 2018
Pediatric Perioperative Nurses and the Ethics of Organ Donation After Cardiac DeathElizabeth A Austin, Pamela Lovett, Wendy C Moore, et al.
Lancet (London, England)|October 2, 2025
Anti-cytokine biologics for asthma in adultsElliot Israel, Michael E Wechsler, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 28, 2025
How to Adjust Asthma Management Once Asthma Is Controlled on Long-Term Biologic TherapyMichael E Wechsler, David J Jackson, Wendy C Moore, et al.
Lancet (London, England)|April 5, 2026
Clinical phenotyping improves choices of biologics in asthma - Authors' replyElliot Israel, David J Jackson, Michael E Wechsler, et al.
Journal of Asthma and Allergy|September 7, 2022
Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE StudyWendy C Moore, Dennis K Ledford, Donna D Carstens, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 9, 2025
Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retrospective analysisWendy C Moore, Alexandra Stach-Klysh, Thomas Corbridge, et al.
Parkinsonism & Related Disorders|July 24, 2020
Levodopa inhalation powder in a patient with persistent asthmaChris Gillette, Jeffrey W Cooney, Caroline B Sisson, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Current Allergy and Asthma Reports|February 25, 2017
Phenotype-Driven Therapeutics in Severe AsthmaMaria Theresa D Opina, Wendy C Moore
Clinics in Chest Medicine|January 30, 2019
Three Major Efforts to Phenotype Asthma: Severe Asthma Research Program, Asthma Disease Endotyping for Personalized Therapeutics, and Unbiased Biomarkers for the Prediction of Respiratory Disease OutcomePhilip E Silkoff, Wendy C Moore, Peter J Sterk
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Difficult-to-Control Asthma Management in AdultsAndrew Menzies-Gow, Wendy C Moore, Michael E Wechsler
AORN Journal|March 30, 2018
Pediatric Perioperative Nurses and the Ethics of Organ Donation After Cardiac DeathElizabeth A Austin, Pamela Lovett, Wendy C Moore, et al.
Lancet (London, England)|October 2, 2025
Anti-cytokine biologics for asthma in adultsElliot Israel, Michael E Wechsler, David J Jackson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 28, 2025
How to Adjust Asthma Management Once Asthma Is Controlled on Long-Term Biologic TherapyMichael E Wechsler, David J Jackson, Wendy C Moore, et al.
Lancet (London, England)|April 5, 2026
Clinical phenotyping improves choices of biologics in asthma - Authors' replyElliot Israel, David J Jackson, Michael E Wechsler, et al.
Journal of Asthma and Allergy|September 7, 2022
Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE StudyWendy C Moore, Dennis K Ledford, Donna D Carstens, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 9, 2025
Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retrospective analysisWendy C Moore, Alexandra Stach-Klysh, Thomas Corbridge, et al.
Parkinsonism & Related Disorders|July 24, 2020
Levodopa inhalation powder in a patient with persistent asthmaChris Gillette, Jeffrey W Cooney, Caroline B Sisson, et al.
Pageof 13